152 related articles for article (PubMed ID: 37313861)
41. [Infantile spasms: experience in 13 cases].
Fonseca LF; Oliveira AL
Arq Neuropsiquiatr; 2000 Jun; 58(2B):512-7. PubMed ID: 10920415
[TBL] [Abstract][Full Text] [Related]
42. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
[TBL] [Abstract][Full Text] [Related]
43. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
[TBL] [Abstract][Full Text] [Related]
44. Steroids or vigabatrin in the treatment of infantile spasms?
Riikonen RS
Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
[TBL] [Abstract][Full Text] [Related]
45. Early diagnosis improving the outcome of an infant with epileptic encephalopathy with cytoplasmic FMRP interacting protein 2 mutation: Case report and literature review.
Zhong M; Liao S; Li T; Wu P; Wang Y; Wu F; Li X; Hong S; Yan L; Jiang L
Medicine (Baltimore); 2019 Nov; 98(44):e17749. PubMed ID: 31689829
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic trial of vigabatrin in refractory infantile spasms.
Chiron C; Dulac O; Beaumont D; Palacios L; Pajot N; Mumford J
J Child Neurol; 1991; Suppl 2():S52-9. PubMed ID: 1940125
[TBL] [Abstract][Full Text] [Related]
47. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms.
Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW
Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423
[TBL] [Abstract][Full Text] [Related]
48. A retrospective study on aetiology based outcome of infantile spasms.
Karvelas G; Lortie A; Scantlebury MH; Duy PT; Cossette P; Carmant L
Seizure; 2009 Apr; 18(3):197-201. PubMed ID: 18976934
[TBL] [Abstract][Full Text] [Related]
49. Favourable prognostic factors with infantile spasms.
Riikonen RS
Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
[TBL] [Abstract][Full Text] [Related]
50. Medication selection, health services outcomes, and cost trajectories for Medicaid beneficiaries with infantile spasms.
Min JY; Knupp KG; Patel AD; Shellhaas RA; Zhang M; Grinspan ZM
Epilepsy Res; 2021 Oct; 176():106733. PubMed ID: 34333373
[TBL] [Abstract][Full Text] [Related]
51. Treatment of infantile spasms.
Haines ST; Casto DT
Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
[TBL] [Abstract][Full Text] [Related]
52. Medical treatment of patients with infantile spasms.
Mikati MA; Lepejian GA; Holmes GL
Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
[TBL] [Abstract][Full Text] [Related]
53. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
[TBL] [Abstract][Full Text] [Related]
54. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
55. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
56. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
57. Response to treatment and outcomes of infantile spasms in Down syndrome.
Harvey S; Allen NM; King MD; Lynch B; Lynch SA; O'Regan M; O'Rourke D; Shahwan A; Webb D; Gorman KM;
Dev Med Child Neurol; 2022 Jun; 64(6):780-788. PubMed ID: 35092693
[TBL] [Abstract][Full Text] [Related]
58. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients.
Mignot C; Moutard ML; Trouillard O; Gourfinkel-An I; Jacquette A; Arveiler B; Morice-Picard F; Lacombe D; Chiron C; Ville D; Charles P; LeGuern E; Depienne C; Héron D
Epilepsia; 2011 Oct; 52(10):1820-7. PubMed ID: 21762454
[TBL] [Abstract][Full Text] [Related]
59. Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study.
Lagae L; Verhelst H; Ceulemans B; De Meirleir L; Nassogne MC; De Borchgrave V; D'Hooghe M; Foulon M; Van Bogaert P
Seizure; 2010 Apr; 19(3):159-64. PubMed ID: 20149693
[TBL] [Abstract][Full Text] [Related]
60. [West syndrome].
Sell-Salazar F
Rev Neurol; 1999 Aug 16-31; 29(4):342-5. PubMed ID: 10797924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
